Buy Tykerb 250mg Lapatinib IP

Tykerb 250mg (Lapatinib IP) is an oral tablet used alongside other medications for certain types of breast cancer treatment. This targeted therapy helps slow cancer cell growth by interfering with specific proteins. Store at 15-25°C and keep out of reach of children.

Strength

250mg

Pack Size

150s

Storage

15-25°

Manufacturer / TM Owner

Novartis

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Tykerb 250mg is primarily used to treat advanced or metastatic HER2-positive breast cancer in combination with other therapies. It may also be prescribed for hormone receptor-positive breast cancer when standard treatments are not effective. Patients often ask what Tykerb 250mg is used for when discussing treatment options with healthcare providers.

Side Effects

This medication works by blocking signals that promote cancer cell growth. Common effects include mild nausea, diarrhea, or fatigue, which may vary by individual. Some patients experience skin changes or reduced appetite during treatment. These effects are typically monitored by a healthcare professional.

Precautions & Warnings

Tykerb 250mg should be taken exactly as prescribed, usually once or twice daily with food. Avoid grapefruit and grapefruit juice, as they may interact with the medication. Regular blood tests and heart monitoring are often recommended during treatment to check for side effects.

Avoid Interactions

Tykerb 250mg may interact with strong CYP3A4 inhibitors or inducers, such as certain antifungals or anticonvulsants. Combining it with other cancer drugs or herbal supplements could affect its effectiveness or increase side effects. Always inform your doctor about all medications and supplements you are taking.

References

Frequently Asked Questions

Tykerb 250mg is used to treat advanced or metastatic HER2-positive breast cancer in combination with other therapies.

Store Tykerb 250mg at room temperature between 15-25°C, away from moisture and direct light.

Yes, Tykerb 250mg is typically taken with food to help with absorption and reduce stomach upset.

Common side effects may include nausea, diarrhea, fatigue, or skin changes, which should be reported to a doctor.

Yes, it may interact with strong CYP3A4 inhibitors or inducers, so always check with a healthcare provider before combining drugs.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.